Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Newsletter
Online Privacy, Credit Cards and Organ Donation
Members of the House Technology & Internet Subcommittee hear testimony on alleged abuses of consumer privacy by internet marketers. President Obama meets with credit card…
Citation
FDA Drug approval delays; new drug called Provenge
Newsletter
Healthy Eating, Big Labor Fights Itself and the War on Mining
A new Food and Drug Administration study sparks debate over the health benefits of eating fish. Factions of the labor union known as UNITE-HERE fight…
Study
The Case for Compensating Live Organ Donors
Full Document Available in PDF Conflicting opinions on the ethics of organ…
Newsletter
Celebrating Earth Day, the FDA Drags Its Feet and Health Scares Debunked
CEI releases a new video titled “Humans Make Earth Day Better.” Promising anti-cancer drug Provenge languishes in the federal approval process despite mounting evidence of…
Comment
CEI Comments on Draft FDA Risk-Benefit Assessment of Fish Consumption
CEI applauds the FDA's even-handed approach.